Sequential Organ Failure Assessment

Sequential Organ Failure Assessment
Name	Sequential Organ Failure Assessment
Specialty	Critical care medicine

Contents

Sequential Organ Failure Assessment

The Sequential Organ Failure Assessment is a clinical tool used in intensive care medicine to assess morbidity and predict outcomes in patients with sepsis, septic shock, and other causes of critical illness. It quantifies dysfunction across multiple organ systems and is applied in settings ranging from intensive care units in tertiary hospitals such as Mayo Clinic, Johns Hopkins Hospital, and Cleveland Clinic to research networks like the Surviving Sepsis Campaign, World Health Organization, and National Institutes of Health. Developed to standardize severity assessment, it informs decisions by clinicians affiliated with institutions including University of Toronto, King's College Hospital, and Imperial College London.

Introduction

The score evaluates six organ systems—respiratory, cardiovascular, hepatic, coagulation, renal, and neurological—using variables measured in routine practice at centers like Massachusetts General Hospital, Mount Sinai Hospital, and Stanford Health Care. It was popularized through multicenter studies involving collaborators from University of Pennsylvania, University of Cambridge, and Harvard Medical School and incorporated into guidelines from organizations such as the European Society of Intensive Care Medicine and the American Thoracic Society. In trials run by consortia including ISRCTN Registry partners and cooperative groups like the NIHR, the tool serves as an endpoint for interventions evaluated at facilities like Karolinska University Hospital and University College London Hospitals.

Each organ domain is scored from 0 to 4 based on quantitative metrics drawn from laboratory and bedside measures used in clinical services at Johns Hopkins Bloomberg School of Public Health and UCLA Health. Respiratory assessment uses the partial pressure of arterial oxygen to fraction of inspired oxygen ratio (PaO2/FiO2), a parameter routinely measured by teams at Seoul National University Hospital and Singapore General Hospital. Coagulation is evaluated via platelet count, a standard assay performed in laboratories at Mayo Clinic Laboratories and ARUP Laboratories. Liver dysfunction is estimated by bilirubin levels, as monitored in hepatology units at Cleveland Clinic Foundation and Royal Free Hospital. Cardiovascular scoring incorporates mean arterial pressure and vasopressor use, reflecting practices described in literature from Brigham and Women's Hospital and Royal Infirmary of Edinburgh. Neurologic status is quantified with the Glasgow Coma Scale, developed at University of Glasgow and taught in programs at Oxford University Hospitals. Renal function uses creatinine and urine output, metrics central to nephrology services at Johns Hopkins School of Medicine and Mayo Clinic Arizona.

Total scores range from 0 to 24, with higher totals indicating greater organ dysfunction, a format referenced in guidelines from the Surviving Sepsis Campaign and analyses published by researchers affiliated with Johns Hopkins University and Columbia University. Clinicians in Vanderbilt University Medical Center, University of California, San Francisco, and Duke University Hospital use serial SOFA calculations to track trends over time, often comparing admission values to 48‑hour changes as described in cohort studies from University of Sydney and Monash University. A change in score (Delta SOFA) is interpreted within decision frameworks used by critical care teams at Bellevue Hospital and Toronto General Hospital to guide escalation or de‑escalation of therapies, a practice aligned with recommendations from the Global Sepsis Alliance.

SOFA is used for risk stratification in randomized controlled trials coordinated by groups like NIH Clinical Center and trial networks such as REMAP-CAP and ACTG. It serves as an outcome measure in interventional studies at academic centers including Yale New Haven Hospital and Vanderbilt University, and as an entry criterion in observational registries run by EuroELSO partners and national databases like Australian and New Zealand Intensive Care Society records. Health systems such as Kaiser Permanente and NHS England employ SOFA-derived data for quality improvement and benchmarking, and it informs triage discussions in emergency departments at Bellevue Hospital Center and Mount Sinai Beth Israel during surges like pandemics managed by Centers for Disease Control and Prevention guidance.

Validation studies across settings from Johns Hopkins cohorts to multinational trials coordinated by World Health Organization collaborators have compared SOFA performance to other scores such as the Acute Physiology and Chronic Health Evaluation and the Simplified Acute Physiology Score. Meta-analyses conducted by researchers at McMaster University and University of Oxford examined discrimination and calibration in diverse populations treated at Addenbrooke's Hospital and Charité – Universitätsmedizin Berlin. The score's predictive accuracy for mortality and length of stay has been tested in specialty cohorts from National Cancer Institute centers, transplant programs at UCSF Medical Center, and cardiovascular ICUs at Mount Sinai Hospital.

Critiques published by investigators from Harvard Medical School, Johns Hopkins Bloomberg School of Public Health, and University of Pennsylvania highlight issues including variability in measurement timing across systems such as Veterans Health Administration hospitals and limited sensitivity for chronic comorbidity burden described in studies from Mayo Clinic and Cleveland Clinic. Other limitations cited in analyses involving European Respiratory Society collaborators include potential misclassification in patients receiving extracorporeal support at centers like Karolinska University Hospital or undergoing organ transplantation at Stanford University Medical Center. Concerns about equitable application in low‑resource settings examined by teams at Makerere University and All India Institute of Medical Sciences have prompted adaptations and simplified scoring approaches.

The instrument originated from collaborative work in intensive care research communities involving contributors from Université Paris Cité, University of Pittsburgh, and University of Melbourne and was formalized through consensus meetings with representatives from institutions such as WHO and professional societies including the European Society of Intensive Care Medicine and the Society of Critical Care Medicine. Subsequent refinements and widespread dissemination occurred via publications and guideline endorsements by bodies like Surviving Sepsis Campaign and academic centers including Johns Hopkins Hospital and Massachusetts General Hospital.

Category:Critical care scoring systems